Circulating fibroblast growth factor‐23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-0895|32|7|685-693

ISSN： 1520-7552

Source： DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol.32, Iss.7, 2016-10, pp. : 685-693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 11, 2015-11 ,pp. : 1152-1157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 305-1870, Iss. 11, 2015-11 ,pp. : 1152-1157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plasma Apolipoprotein B Levels Predict Platelet-Dependent Thrombosis in Patients with Coronary Artery Disease

By  

Cardiology, Vol. 92, Iss. 3, 2000-03 ,pp. : 151-155

Karger

Access to resources Recommend Favorite

Elevated Cardiac Troponin Levels Do Not Predict Adverse Outcomes in Hospitalized Patients without Clinical Manifestations of Acute Coronary Syndromes

By  

Cardiology, Vol. 93, Iss. 1-2, 2000-07 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Interleukin 6(-174G/C) Variant and its Circulating Levels in Coronary Artery Disease Patients and Their First Degree Relatives

By Galimudi Rajesh   Spurthi Mrudula   Padala Chiranjeevi   Kumar Kishore   Mudigonda Saraswati   Reddy Srilatha   Aiyengar Mohini   Sahu Sanjib   Rani Surekha  

Inflammation, Vol. 37, Iss. 2, 2014-04 ,pp. : 314-321

Springer Publishing Company

Access to resources Recommend Favorite